Pretax income is the income that a company earns before paying income taxes. Nevro's pretax income for the
three
months ended in Mar. 2024 was $-25.0 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-88.2 Mil.
Nevro's pretax margin was -24.56%.
During the past 12 years, Nevro's highest Pretax Margin was 1.05%. The lowest was -95.20%. And the median was -22.86%.
Nevro Pre-Tax Income Historical Data
The historical data trend for Nevro's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nevro's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nevro's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nevro's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Nevro's Pre-Tax Income falls into.
Nevro Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Nevro's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-88.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nevro (NYSE:NVRO) Pre-Tax Income Explanation
Nevro's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 12 years, Nevro's highest Pretax Margin was 1.05%. The lowest was -95.20%. And the median was -22.86%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nevro Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Nevro's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVRO has been successfully added to your 